Prerpints.org logo
Preprint
Review

Exploratory Review of Takotsubo Syndrome and the Possible Role of the Psychosocial Stress Response and Inflammaging

Altmetrics

Downloads

109

Views

29

Comments

0

A peer-reviewed article of this preprint also exists.

This version is not peer-reviewed

Submitted:

13 December 2023

Posted:

14 December 2023

You are already at the latest version

Alerts
Abstract
Takotsubo syndrome (TTS) is a cardiomyopathy that presents clinically as a transient and reversible left ventricular wall motion abnormality (LVWMA) that can recover spontaneously within hours to weeks. Studies have shown that it mainly affects older people. Postmenopausal women in particular have an increased prevalence. Physical and emotional stress are widely discussed and generally recognized trigger factors. As age also appears to play a major role in the development of TTS, this review will take a closer look at age- and gender-specific aspects. First and foremost, postmenopausal women and the associated lower oestrogen concentration should be mentioned here. Another important role is played by the hypothalamic-pituitary-adrenal (HPA) axis and the associated glucocorticoid-dependent negative feedback and the resulting immune response. Inflammaging is another term that is increasingly used in connection with TTS. In the following, these risk factors are considered in more detail and linked to the increased sympathetic activity as a possible consequence of chronic stress. Based on the imbalance between the sympathetic and parasympathetic nervous system, we venture an explorative proposal and would like to present a new possible therapeutic approach.
Keywords: 
Subject: Medicine and Pharmacology  -   Cardiac and Cardiovascular Systems

1. Introduction

Takotsubo syndrome (TTS) is a disease associated primarily with emotional and physical trigger factors (1). Since it is multifactorial, it is better summarized under the term "syndrome". In the past, TTS has been described in literature under many different names, such as "stress cardiomyopathy", "broken heart syndrome" or "apical ballooning syndrome" (2). However, none of these terms accurately describes the ventricular akinesis that may occur in this syndrome. Unlike other cardiomyopathies such as acute coronary syndrome (ACS), which are usually non-transient, TTS is characterized by a transient and reversible left ventricular wall motion abnormality (LVWMA) that can recover spontaneously within hours to weeks.
The most common clinical symptoms are dyspnea, acute chest pain, and/or syncope. However, it is difficult to diagnose TTS based on these symptoms alone. For example, patients with TTS affected by emotional stressors are more likely to present with chest pain and palpitations (3), whereas patients triggered by physical stressors are more likely to clinically manifest an acute illness.
Unfortunately, TTS is very similar to ACS in terms of clinical presentation and ST-segment elevations, making it extremely difficult to distinguish while onset. Approximately 2-3% of patients with the clinical presentation of ACS actually suffer from TTS (4,5). Currently, there are no reliable electrocardiogram (ECG) criteria to clearly distinguish ST-segment elevation myocardial infarction from TTS. This makes resolving the differential diagnosis in TTS disease that much more significant.
In this term, echocardiography, as an important component of cardiac imaging studies, holds an essential part in the diagnostics of the heart. Cardiac imaging studies should not only concentrate on being performed as soon as possible during patient presentation, but should also be repeated consistently thereafter.
Besides, cardiac magnetic resonance (CMR) imaging is helpful in delivering information to differentiate TTS from diseases which cause irreversible myocardial damage such as myocarditis or myocardial infarction (6).
To date, four major types of TTS variants can be differentiated based on the regional wall motion abnormalities.
The most recognized forms are I) apical ballooning type (7, 8), II) midventricular type, III) basal and IV) focal wall motion patterns (8).
Recent studies dedicate themselves to the issue of diagnosis TTS, by investigating sensitive and specific biomarkers for cardiovascular diseases in blood samples. microRNAs (miRNAs/miRs) have been identified as very promising biomarkers to differentiate ST-elevation myocardial infarction (STEMI) patients form TTS patients (9, 10).
In addition to physical and emotional triggers, female sex and age-related deficiency of female sex hormones are known to trigger TTS, and now inflammation is also being discussed as an emerging pathophysiologic mechanism (1, 11).
In this review, we will discuss alternative, novel, unrecognized, and underappreciated potential trigger factors and address the most common diseases associated with TTS. Emphasis will be placed on gender differences, particularly sex hormone differences, and aging, more specifically inflammaging as an underappreciated risk factor. In addition, we would like to draw attention to the possibility of transcutaneous vagus nerve stimulation (tVNS) treatment, as we have shown that stimulation of the parasympathetic nervous system via the vagus nerve (VN) has significant anti-inflammatory effects (12). Attenuation of low-grade inflammation could be useful in suppressing stress responses and trigger events that could lead to TTS (13-15).

2. Brain-Heart Interaction/Axis

The cardiovascular system is associated with the regulation throughout the cortical modulation. Although there is still a lack of knowledge on the mechanism of the “brain-heart-axis”, various cardiac and neurological diseases have been discussed to be influenced by each other. High levels of the named pro-inflammatory markers are seen in the majority of elder people, even without acute diseases.
The cortical modulation is a network mainly composed of the insular cortex (Ic), the anterior cingulate gyrus, and the amygdala. This network plays a crucial role in the regulation of the central autonomic nervous system (CAN), e.g. through physical triggers or emotional stressors such as anxiety, excitement, and sadness.
The Ic is located at the base of the Sylvian fissure, with the middle central cerebral artery running in close proximity. Functionally, the Ic can be divided into the right insula, which is associated with sympathetic dominance, meaning that stimulation leads to an increase in heart rate and pressor responses, and the left insula, which is characterized by the parasympathetic tone, leading to a decrease in heart rate and an increase in depressor responses (16).
In addition, the Ic is associated with autonomic, sensory, and motor functions, as well as its bidirectional connections to other brain areas such as the limbic system.
Studies using functional magnetic resonance imaging (fMRI) of the brain to monitor resting-state functional connectivity demonstrated hypoconnectivity of parasympathetic and sympathetic-associated subnetworks of central brain regions and limbic regions in TTS patients compared with control groups (17).
In addition several studies have attempted to demonstrate a link between activation of the Ic and the processing of emotions such as anxiety, fear, anger, panic, and joy (18-21). The anterior part of Ic has been shown to be decisively involved in the processing of emotions (22).
This suggests that the processing of emotions by the anterior part of Ic, has an influence on the autonomic nervous system and may shift the sympatho-vagal balance toward a sympatico-dominant status.
In regard of the current knowing of the cortical modulation network, with main involving parts of the Ic, sympatho-vagal balance is key for homeostasis. And a destructed Ic firmly leads to an imbalance with effects on the cardiovascular system and support to develop TTS. Different factors come in mind to a disruption of the Ic, whether it is a hemorrhage stroke of the middle central cerebral artery, sexual hormones such estrogen or the processing of emotions.
It is known that psychological and physical stressors recruit different brain nuclei to respond to stress. In fact, activation of the autonomic nervous system (ANS) and neuroendocrine system is central and causes behavioral changes (23).
When this self-regulation is disrupted, stress becomes harmful and the body’s susceptibility to diseases such as cardiovascular, psychiatric and immune disorders increases (24, 25). In the stress response, the locus coeruleus (LC), the amygdala nuclei, the septal-hippocampal complex, the paraventricular nucleus of the hypothalamus (PVH), the prefrontal and cingulate cortexes, and the parabrachial and raphe nuclei play an important role in the stress response. The resulting signals stimulate the hypothalamic-pituitary-adrenal (HPA) axis.
In the signaling chain, the PVH is responsible for the release of the corticotropin-releasing factor (CRF), which induces the release of the adrenocorticotropin hormone (ACTH) by the anterior pituitary gland. ACTH in turn initiates the secretion of glucocorticoids (GC) by the adrenal glands (26, 27).
Since CRF can be produced in the central nervous system (CNS), but also in the periphery, it is crucial for the coordination of some physiological systems (28).
Indeed, CRF modulates the stress-induced sympathetic response and is important for central and peripheral release of norepinephrine (NE) during stress events (29). This is important to link physiological and behavioral changes and the perception of stress.
Chronic and acute stress utilize different pathways to alter CAN control and autonomic response (23, 30).
In chronic stress situations, a sustained increase in the excitability of the adreno-medullary axis and the HPA is thought to result in increased NE synthesis (28). The question arises as to whether the loss of GC self-regulation in the PVH and pituitary gland is of crucial importance in impaired stress management.
The loss of GC self-regulation can be explained by the interruption of negative GC feedback and the associated persistent activation and maintenance of elevated systemic GC levels. Due to the higher availability of these hormones, brain structures such as the amygdala and LC enhance the activation of the HPA axis and promote changes in behavior and normal physiology (30-32).
Persistently elevated systemic GC levels can trigger immunosuppression and promote the development of autoimmune diseases and also mood disorders (33).
In this context, the term chronic unpredictable stress (CUS) should be mentioned. This is an established model that describes mood disorders and stress-induced plasticity of the brain. These are physiological and physical stressors and a lack of adaptability to various stressful stimuli that are similar to everyday life stressors (34, 35). In this context, the role of NE release and loss of HPA self-regulation is under discussion (36).
Interestingly, recent reports (13) were able to highlight that TTS patients in different disease phases exhibit the presence of many validated biological and psydhological markers of chronic stress as defined in the Trier Social Stress Test (TSST) (37)…using blood biosamples from TTS patients: the authors consistently showed the presence of elevated IL-6, TNF-α, NFkB, elevated blood cortisol, DHEA, aldosterone, adrenaline, noradrenaline and dopamine levels, so that chronic psychosocial stress as an underlying factor fueling TTS development needs to be acknowledged (38).

3. Pathophysiology (Physical and Emotional Triggers)

It is currently believed that TTS is primarily caused by physical and emotional triggers, but psychological and psychosocial stress factors may also play a greater role than previously thought. The most important risk factors currently associated with TTS are discussed below.

4. Triggers

There is widespread agreement that a major feature of the development of TTS is associated with a stressful event. The most common reason preceding such an event is an emotional or physical trigger. According to some research, physical triggers are more common than emotional stressors, which may also have gender-specific aspects. For example, men seem to be more likely to respond to physical events, whereas women are more likely to be affected by emotional events (7). Psychological and psychosocial stressors must be identified in this context. Currently, very little is known about the living conditions of patients with TTS. Wallström et al. (38) studied postmenopausal women who were burdened by psychological and psychosocial stress. The patients reported that they felt burdened by responsibility, injustice and uncertainty long before the onset of Takotsubo syndrome. This long-term stress wore down the respondents’ defenses to such an extent that even the smallest stressors threw them off balance. The results indicate that the social structure of gender can also contribute to the respondents’ condition. These factors may be reflected in the high number of female respondents. Looking at the number of cases of TTS patients by gender, the significant difference in the prevalence of TTS between women and men may also be due to the social position and role of women in some countries and cultures.
These triggers do not have to occur individually, but can also occur as a combination of triggers (e.g., a panic attack, an emotional event following surgery or an accident).

5. Emotional Stressors

Emotion is an open term that includes not only traumatic emotions, which are feelings based on traumatic events. It encompasses interpersonal conflicts, anxiety, fear or anger, but also financial/ professional problems or environmental disasters that have a profound emotional impact on the individual (39-41). Stressors do not absolutely have to be all negative, as positive emotions can also trigger TTS. Examples include weddings, surprise parties, or a job offer (42).
As far as stressors are concerned, it is probably not the type of emotion that is decisive, but the harshness of a single event or the combination of several emotions that are insignificant in themselves.

6. Physical Stressors

In addition to emotional stressors, physical stressors play a just as important role in the development of TTS. The term physical stressors includes almost any exogenous, stress-inducing event. Thus, it goes over extremely strenuous activities, medical illnesses (e.g., surgeries (43), traumatic injuries, radiotherapy (44), sepsis (45), or pregnancy (46), to name a few), substance abuse, to nervous system disorders. Among them, mainly conditions such as head trauma (47), stroke (43), seizures (48), and intracerebral hemorrhage (49) can be summarized, which are associated with the onset of TTS.

7. Gender Differences in TTS

According to various reports, the severity of TTS is often higher in men than in women. This contrasts with the expression of the disease. Here, women, but especially postmenopausal women are much more frequently affected by TTS (50).
Considering the proportion of gender differences in USA, Europe, and Japan, although there are varieties from report to report in proportion of males developing TTS, one thing is significant, females are predominantly affected by TTS.
As TTS is a relatively rare disease, data is currently only being raised from US National Inpatient Sample registry (51), The International Takotsubo Registry (7), Tokyo Cardiovascular Care Unit (50) and the Cardiovascular Research Consortium-8 Universities: CIRC-8U (52).
Tokyo Cardiovascular Care Unit can´t recognize significant differences in clinical appearances between females and males, but the median age at hospitalization of male patients due to female patients were slightly younger (male = 72 years, female = 76 years). In fact, this study claims, prior physical stress is more common in male (50%) than in female (31.3%) patients (p = 0.002). In contrast, female patients are more addicted to emotional stress (male: 19.0% vs. female: 31.0%, (p = 0.039) (50). According to reports from the International Takotsubo Registry (7), 29.2% of females and about 14.5% of male (p < 0.001) developed the disease due to emotional stress, whereas 34.3% of females and 50.8% of males evolves TTS through physical stress. This is very similar to the Japanese reports (52).
From these reports, it can be concluded that men respond primarily to physical stressors, whereas women tend to respond more to emotional stressors.
Preprints 93222 i001
Although the pathophysiology of TTS is poorly understood, TTS is primarily explained by stress responses, as previously pointed out. This may be due to differences in stress response between the sexes.
It is interesting to note that most patients are postmenopausal women. With regard to their propensity to emotional stress as a trigger for TTS, the effects of estrogen concentration may have a greater impact than previously thought, which requires further investigation.
It is assumed that women show stronger immune responses against foreign but also against self-antigens. Furthermore show women a higher prevalence to autoimmune diseases than compared to men. An important role in the activity of immune cells is due to the different attribution to sex hormones between men and women (4, 53).
The Cidlowski group was able to show in experimental rat models that males and females show a difference in the prevalence of many major diseases due to inflammatory components.
Interestingly, a link between inflammatory diseases and sexually dimorphic effects of glucocorticoids may be important for the sex-specific differences in prevalence.
Based on the outcome of these studies, the anti-inflammatory effects of glucocorticoid-receptors (GR) appear to be more effective in men, whereas a lack of GR may promote certain diseases in women. This has been documented in vivo in the liver in a sepsis model of systemic inflammation (54).
This suggests that a priming mechanism in homeostatic female animals ensures a faster response to inflammatory stimuli, so that the expression of the most frequently regulated proinflammatory genes is induced to a greater extent in female mice.
Not only emotional stress can be an important trigger in postmenopausal women, but also behavioral stress reactions, psychologic stress and estrogen concentration. Studies have shown that there are significant differences between pre- and postmenopausal women in their reactions to psychological stress. Importantly, estrogen appears to attenuate the effect of stress-induced reactions. This means that in TTS the stress response could be exacerbated, as there is an imbalance in androgen/ estrogen levels (55).
In addition, the dexamethasone/corticotropin-releasing hormone (Dex-CRH) test indicates that the negative feedback of the HPA axis is altered in older women.
This is shown by studies of psychological and endocrine responses to psychosocial stress and Dex-CRH in healthy postmenopausal women and young controls. In addition, the current data suggest that estradiol supplementation appears to modulate HPA feedback sensitivity in humans (56).

8. How Does Estrogen Concentration Affects Postmenopausal Women?

Considering the much discussed gender differences in TTS, the number of postmenopausal women is alarming. This raises the question of the importance of sex hormones and their influence on the development of TTS.
In this context, a possible role of estrogen deficiency in TTS is currently very much in focus. The severe effects of a reduction in estrogen levels are underlined by the high number of postmenopausal women who develop TTS. An animal study investigated two groups of female rats: group 1 were ovariectomized (OVX) female rats and group 2 were those that were ovariectomized but also supplemented with estradiol (OVX+E). They were all subjected to immobilization stress to evaluate cardiac changes. In the OVX rats, contraction of left ventriculography was significantly reduced, whereas no sizeable responses were observed in the OVX+E rats. In addition, both groups exhibited significantly increased heart rate, although the heart rate of the OVX rats was higher (57, 58).
From this and from the results of Rivera et.al. (59) showing that patients who underwent bilateral oophorectomy, as opposed to unilateral oophorectomy, had a higher mortality due to cardiovascular events. On the basis of this, it can be suggested that estrogen substitution may positively influence the risk of developing cardiovascular events due to emotional stress.
Currently, estrogen is thought to have a cardioprotective effect and to suppress the sympathetic nervous system:
Evidence for the cardioprotective effect of estrogen can be found, for example, in a study by Brenner et. al. In the study, postmenopausal women with TTS were compared with age- and sex-matched patients with myocardial infarction (MI) or patients with normal coronary arteries. The aim was to investigate the different influences of sex hormones (estradiol (E2), progesterone (P), luteinizing hormone (LH), and follicle-stimulating hormone (FSH)) during onset and long-term follow-up.
Interestingly, E2 levels were significantly higher in TTS patients at hospital admission, whereas no changes were observed in MI patients and the control group. This suggests that elevated E2 concentrations have a cardioprotective effect (60).
There are different approaches to how estrogen concentration in postmenopausal women may influence the development of TTS.
In postmenopausal women, estrogen concentration is significantly reduced and is supposed to accelerate aging and enhance the rate of mortality due to cardiovascular events (59). This information is supported by investigations of Multi-Ethnic Study of Atherosclerosis (MESA), which report of a 12 years follow-up of 2834 menopausal women with an increased testosterone/estradiol ratio, which is brought in context with the incidence of heart failure with reduce ejection fraction (HFrEF) (61).
Currently, the role of estradiol in the regulation of the energy metabolism is being discussed (62). An animal study by Zhu et al. (63) revealed new insights into the regulation of blood pressure and vascular function, in which estrogen receptor alpha (ERα) and ERβ play a central role. ERs were confirmed to express blood vessels and influence vasoconstriction. In addition, it has been shown that persistent systolic/diastolic hypertension develops in aging ERβ-deficient mice.
Furthermore, estrogens have been observed to reduce the sympathetic response to psychological stress and reduce catecholamine-induced vasoconstriction(64, 65). In addition, endothelial nitric oxide (NO) synthase can be influenced to modulate vasomotor tone (66).
Whether estrogen has exclusively indirect effects (via the nervous and/or vascular systems) or also direct effects on the cardiomyocyte has not yet been conclusively determined. In the study by Förster et al. (67), myocardial disarray, disrupted intercalated slices, profound changes in nuclear structure, and increased number and size of gap junctions were observed, but no ERβ was found in the myocardium (67), which strengthens the hypothesis that estrogen acts indirectly on the myocardium.
Although there are differences in the clinical presentation of HFrEF and TTS, low estrogen levels could be considered a common risk. This could be supported by the fact that the postmenopausal status is an underlying pathophysiological feature in both TTS and HFrEF. To better understand the pathological mechanism and the influence of sex hormones, further studies need to be performed with both male and female case groups.
Another interesting aspect to investigate, is the functional cerebral asymmetry, in particular the influence on Ic activity in the modulation network. As discussed earlier, we can distinguish between a right cortex associated with sympathetic activity and control of emotional stimuli and the left hemisphere dominated by parasympathetic tone of the heart (42, 68).
Estrogen in particular has been found to cause a correlation with left hemisphere activation (69). This leads to the suggestion that low estrogen levels promote left hemisphere inactivation. It can be concluded that low estrogen may shift the sympathovagal balance toward sympathetic activity. This can be explained by the different associations of the hemispheres to the sympathetic and parasympathetic nervous systems.
As previously discussed, low estradiol levels in postmenopausal women have been named as a possible promoter of TTS. Studies have shown that low E2 is associated with a higher risk of developing TTS. In this context, the responsiveness of older women to the effects of age and estrogen on stress needs to be closely examined:
As noted earlier, HPA function may play a greater role in chronic stress as well as in the behavioral response to stress. In this context, one study has examined HPA function as influenced by circulating estradiol levels and hormonal status during the stress response. In relation to psychosocial stress, the results showed an enhanced response of the HPA axis during the low-estrogen phase of the menstrual cycle compared to the high-estrogen phase and additionally during menopause (55).
In their studies, Lindheim et al. (55) were able to demonstrate significant differences in the reactions to psychological stress between premenopausal women and postmenopausal women. They pointed out that this could also be a reason for the higher prevalence of cardiovascular disease in women. This is a very interesting but also alarming aspect that postmenopausal women may be more affected by psychosocial stress than men due to low estrogen levels.

9. Sympathetic Nervous System

However, the pathophysiological mechanisms of TTS have not been fully elucidated to date. Studies strongly suggest that it is closely related to the sympathetic nervous system stimulation. A significant proportion of patients who experience TTS can be attributed to emotional and physical stressors (70-72). The stress response is mediated by anatomical structures of the central nervous system and various peripheral organs. In this context, emotional stressors, for example, can lead to brain activation followed by an increase in concentrations of cortisol, epinephrine, and NE.
The neocortical complex and the limbic system, which are responsible for classifying events as "threatening," lead TTS patients to overreact to physical or emotional triggers. This is followed by stimulation of the sympathetic nervous system (SNS). Sympathetic activation can be explained by two neurohumoral axes:
1) The sympathetic-adrenal axis is activated by immediate stressors and is characterized by catecholamine release from the adrenal medulla. Note that adrenal medullary catecholamine release is an essential component of the neuroendocrine stress response axis.
2) In contrast, the HPA is increasingly activated by chronic stressors. This is caused by a continuous release of cortisol from the adrenal cortex (73).
The stress response is a complex process involving multiple pathways and components, including behavioral, endocrine and autonomic changes that lead to a coordinated response (23). Some of these pathways are associated with activation of the hypothalamic-pituitary-adrenal axis (26, 27).
In individuals with inadequate self-regulation, stress can have detrimental effects and cause pathologies (25), e.g. through excessive inflammation.
Interestingly, the animal study presented here, in which male rats were exposed to chronic unpredictable stress (CUMS), showed increased expression of GR in response to CUMS. In this study, Malta et al. (36) highlight that GR plays a role in fine-tuning CUMS responses, which have been shown to depend on GC and NE signaling in male rats.
Specifically, 14 days of CUMS administration was shown to induce sustained hyperactivity of the HPA axis in male rats. This was reflected in an increase in plasmatic corticosterone and adrenal hypertrophy, both of which were dependent on increased GC and NE release triggered by each stress session. CUMS exposure had also increased CRF2 mRNA expression and GR protein levels in basic brain structures related to HPA regulation and behavior (36).
This rationale was reinforced by the observation that repeated stress (CUMS) correlates with increased GR expression in the spleen (74).
GC are stress-induced steroids that not only have inflammatory and immunosuppressive effects, but also regulate the function and development of the central nervous system (upregulation of sympathetic nerve activity and downregulation of the parasympathetic drive), intermediary metabolism, vascular tone and, above all, the process of programmed cell death (75, 76).
A consistent trend towards increased GR levels has been observed in the serum of TTS patients (11).
The focus is on the fact that activation of the HPA axis and the sympathetic nervous system, which play an important role in TTS, is associated with increased peripheral proinflammatory markers in the blood, especially in chronic stress (77). Currently, there is little empirical evidence that peripheral levels of glucocorticoids and/or catecholamines mediate this effect.
An established model is of significance here, in which chronic stress leads to GR resistance, which in turn results in an upregulation of GR levels and a lack of downregulation of the inflammatory response.
Currently, attention is focused on the possibility that cellular sensitivity to these ligands contributes to the inflammatory mediators that accompany chronic stress. A link between chronic stress and the sensitivity of the glucocorticoid receptor (GR) and the β-adrenergic receptor (β-AR) has been hypothesized.
Studies have shown that glucocorticoid resistance associated with β2-adrenergic receptor signaling pathways promotes peripheral proinflammatory states associated with chronic, psychological stress (78).
Interestingly, research shows similar results with social stressors in mice, primates and humans, as chronic stress is associated with upregulation of pro-inflammatory gene transcription. Notably, a significant downregulation of GR sensitivity was observed, which could lead to increased GR expression. These stress-related findings are also associated with an atypical intracellular β-AR signaling pathway. However, its significance in TTS still requires further investigation (78-83).
GR expression has been described as a suitable surrogate marker in various stressful situations, such as post-traumatic stress disorder or the observed glucocorticoid resistance in chronic stress (84).
As explained earlier, in most cases TTS is triggered by an emotional or physical event, but diseases such as pheochromocytoma or other central nervous system disorders closely associated with catecholamine excess can also cause TTS-like dysfunction and should not be forgotten. More detailed investigations as they relate to TTS are essential.
Intravenous administration of catecholamines and beta-agonists to induce TTS and other ballooning patterns is clear evidence. Several animal studies suggest that adrenergic activation plays an important role in the development of TTS (85).
Supporting the important influence of sympathetic stimulation is the increased level of norepinephrine in the coronary sinus of TTS patients, due to an increased local release of myocardial catecholamines (86). Another aspect supporting the influence of the sympathetic stimulation is the analysis of heart rate variability. During the acute phase, a suppression of the parasympathetic activity is observed (87). This is in line with some microneurographic studies, demonstrating a decreased baroreflex control in TTS patients (88).
Although there is now strong evidence that sympathetic activation plays a central role in TTS, the effects of catecholamine excess on the various ballooning patterns characteristic of TTS have not been truly elucidated. So far, several suggestions have been made that seem reasonable. For example, it has been suggested that a catecholamine surge may lead to myocardial damage. In this context, several mechanisms can be mentioned, such as adrenoreceptor-mediated damage and microvascular coronary vasoconstriction, which increase cardiac work(89).

10. Inflammaging

Inflammaging is a term that has become associated with aging and age-related diseases. It is a low-grade, sterile, and chronic inflammation that worsens with age. This contributes to the pathogenesis of age-related diseases. Inflammation is an important characteristic of aging and other comorbidities associated with age-related decline, such as neurodegeneration, Alzheimer’s disease, age-related macular degeneration, age-related hearing loss, and type 2 diabetes.
Dysregulation of the immune system is strongly associated with aging, and obvious features are high blood levels of pro-inflammatory markers, e.g., interleukin (IL) -1, -6, -8, tumor necrosis factor (TNF), and C-reactive protein (CRP) (90-93).
One of the most important features associated with aging is a decrease in autophagy mechanisms (94). Autophagy describes the cellular housekeeping mechanisms to eliminate dysfunctional intracellular proteins that primarily prevent activation of inflammatory responses. In contrast, the consequence of an age-related decline in autophagy mechanisms is increased activation of inflammatory responses and an increase in pro-inflammatory markers (95).
Another important component that affects inflammation are the telomeres, repetitive deoxyribonucleic acid (DNA) sequences located at the end of chromosomes to protect them from fusion or decay. The problem is that they shorten with each cell division and can eventually lead to senescence and death. For example, a study from the Health, Ageing and Body Composition Study (96) shows a correlation between shorter telomere lengths and inflammatory markers such as increased IL-6, TNF (96, 97). Other studies have shown a correlation with CRP (98) and chronic inflammatory diseases of the lung and kidney (99).
Based on current knowledge, " inflammaging" seems to be very well described under the term of age-related low-grade, sterile, chronic inflammation. In the context of what we know about the pathophysiology of TTS, we can see similarities to inflammaging that indicate a link. This is especially the case given the age distribution of TTS patients and the elevated proinflammatory markers in blood samples from hospitalized TTS patients (11).
In particular, with regard to emotional or physical triggers, low-grade chronic inflammation could be crucial for the onset of TTS, as it mainly affects people between 60 and 80 years of age.
Since TTS seem to be clearly correlated with age-related chronic inflammation, we could ask for a new treatment option using tVNS. As we have shown in our recent research, there is a strong correlation between chronic inflammation and hyperactivity of the sympathetic nervous system. While anti-inflammatory results were observed when the parasympathetic nervous system was stimulated (12). This leads to the assumption that stimulation of the VN could also have positive effects in the prevention of TTS, a stress-induced cardiomyopathy.
Although there are still very few data on inflammation associated with TTS, it should not be underestimated as a risk factor and further investigation should be considered.

11. Conclusions

The latest findings suggest that CUS/CUMS plays a greater role in the development of TTS than previously thought (74). In particular, it concerns the link between chronic psychological stress and a decrease in GR and β-AR sensitivity. Resistance leads to overexpression of GR and dysregulation of the HPA axis. The dysregulated negative feedback leads to increased GC levels and long-term immunosuppression (Figure 1).
There is also clear evidence that increased GR resistance is associated with proinflammatory states in the periphery. This can be explained by the fact that an upregulation of proinflammatory gene transcription has been observed in chronic and psychological stress (77, 78).
In particular, postmenopausal women with reduced estrogen concentrations show an altered response of the HPA axis.
The studies by Lindheim et al. (55) also show that there are differences in the reaction to psychological stress between pre- and postmenopausal women. This may be a further indication that women have an increased prevalence of cardiovascular disease.
Due to the disturbed self-regulation of the HPA axis, increased peripheral inflammatory markers are suspected, which are associated with inflammaging, altered CAN control and an increased corticosteroid response. This results in increased sympathetic activity and reduced parasympathetic activity. TTS could arise from this imbalance.
This is exactly the point at which tVNS treatment comes into question. Our research has shown that tVNS has a positive effect on parasympathetic activity and plays an important role in the depression of chronic pro-inflammatory markers.
With regard to applicability, clinical studies and results are currently still lacking and should be the subject of further research in the future.
Preprints 93222 g001
Figure 1. Potential contribution of chronic stress and inflammaging to TTS susceptibility. Novel concept for TTS development, involving underlying chronic stress, glucocorticoid resistance, alteres immune response culminating in inflammaging and alteres control CAN, βAR signaling. The integration of these effects might enhance susceptibily to TTS following an acute trigger.
Figure 1. Potential contribution of chronic stress and inflammaging to TTS susceptibility. Novel concept for TTS development, involving underlying chronic stress, glucocorticoid resistance, alteres immune response culminating in inflammaging and alteres control CAN, βAR signaling. The integration of these effects might enhance susceptibily to TTS following an acute trigger.
Preprints 93222 g001

Funding

This work was supported by grants DFG Fo 315/5-1 and investment contribution of foundation Forschung hilft to CYF.

Abbreviations

TTS takotsubo syndrome
ACS acute coronary syndrome
LVWMA left ventricular wall motion abnormality
ECG electrocardiogram
CMR cardiac magnetic resonance
STEMI ST-elevation myocardial infarction
tVNS transcutaneous vagus nerve stimulation
VN vagus nerve
Ic insular cortex
CAN central autonomic nervous system
fMRI functional magnetic resonance imaging
ANS autonomic nervous system
LC locus coeruleus
PVH paraventricular nucleus of the hypothalamus
HPA hypothalamic-pituitary-adrenal
CRF corticotropin-releasing factor
ACTH adrenocorticotropin hormone
GC glucocorticoid
NE norepinephrine
CUS/CUMS chronic unpredictable stress/ chronic unpredictable mild stress
GR glucocorticoid-receptor
OVX ovariectomized
E2 estradiol
P progesterone
LH luteinizing hormone
FSH follicle-stimulating hormone
MI myocardial infarction
MESA Multi-Ethnic Study of Atherosclerosis
HFrEF heart failure with reduce ejection fraction
Erα/β estrogen receptor alpha/beta
NO nitric oxide
SNS sympathetic nervous system
β-AR β-adrenergic receptor
IL interleukin
TNF tumor necrosis factor
CRP C-reactive protein
DNA deoxyribonucleic acid

References

  1. Ghadri, J.R.; Wittstein, I.S.; Prasad, A.; Sharkey, S.; Dote, K.; Akashi, Y.J.; et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018, 39, 2032–2046. [Google Scholar] [CrossRef] [PubMed]
  2. Sharkey, S.W.; Lesser, J.R.; Maron, M.S.; Maron, B.J. Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature. J. Am. Coll. Cardiol. 2011, 57, 1496–1497. [Google Scholar] [CrossRef] [PubMed]
  3. Song, B.G.; Yang, H.S.; Hwang, H.K.; Kang, G.H.; Park, Y.H.; Chun, W.J.; et al. The impact of stressor patterns on clinical features in patients with tako-tsubo cardiomyopathy: experiences of two tertiary cardiovascular centers. Clin. Cardiol. 2012, 35, E6–E13. [Google Scholar] [CrossRef] [PubMed]
  4. Lyon, A.R.; Bossone, E.; Schneider, B.; Sechtem, U.; Citro, R.; Underwood, S.R.; et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2016, 18, 8–27. [Google Scholar] [CrossRef] [PubMed]
  5. Elgendy, A.Y.; Elgendy, I.Y.; Mansoor, H.; Mahmoud, A.N. Clinical presentations and outcomes of Takotsubo syndrome in the setting of subarachnoid hemorrhage: A systematic review and meta-analysis. Eur. Heart J. Acute Cardiovasc. Care 2018, 7, 236–245. [Google Scholar] [CrossRef] [PubMed]
  6. Eitel, I.; von Knobelsdorff-Brenkenhoff, F.; Bernhardt, P.; Carbone, I.; Muellerleile, K.; Aldrovandi, A.; et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. Jama 2011, 306, 277–286. [Google Scholar] [CrossRef] [PubMed]
  7. Templin, C.; Ghadri, J.R.; Diekmann, J.; Napp, L.C.; Bataiosu, D.R.; Jaguszewski, M.; et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N. Engl. J. Med. 2015, 373, 929–938. [Google Scholar] [CrossRef] [PubMed]
  8. Ghadri, J.R.; Cammann, V.L.; Napp, L.C.; Jurisic, S.; Diekmann, J.; Bataiosu, D.R.; et al. Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome: Data From the International Takotsubo Registry. JAMA Cardiol. 2016, 1, 335–340. [Google Scholar] [CrossRef] [PubMed]
  9. Couch, L.S.; Fiedler, J.; Chick, G.; Clayton, R.; Dries, E.; Wienecke, L.M.; et al. Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure. Cardiovasc Res. 2022, 118, 1758–1770. [Google Scholar] [CrossRef]
  10. Jaguszewski, M.; Osipova, J.; Ghadri, J.R.; Napp, L.C.; Widera, C.; Franke, J.; et al. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. Eur. Heart J. 2014, 35, 999–1006. [Google Scholar] [CrossRef]
  11. Nagai, M.; Shityakov, S.; Smetak, M.; Hunkler, H.; Bär, C.; Schlegel, N.; et al. Blood Biomarkers in Takotsubo Syndrome Point to an Emerging Role for Inflammaging in Endothelial Pathophysiology. Biomolecules 2023, 2023, 995. [Google Scholar] [CrossRef] [PubMed]
  12. Frank, N.; Nagai, M.; Förster, C. Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy. Explor. Neuroprotective Ther. 2023, 363–397. [Google Scholar] [CrossRef]
  13. Nagai, M.; Shityakov, S.; Smetak, M.; Hunkler, H.J.; Bar, C.; Schlegel, N.; et al. Blood Biomarkers in Takotsubo Syndrome Point to an Emerging Role for Inflammaging in Endothelial Pathophysiology. Biomolecules 2023, 13. [Google Scholar] [CrossRef] [PubMed]
  14. Ittner, C.; Burek, M.; Stork, S.; Nagai, M.; Forster, C.Y. Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells in vitro. Front. Cardiovasc. Med. 2020, 7, 73. [Google Scholar] [CrossRef] [PubMed]
  15. Karnati, S.; Garikapati, V.; Liebisch, G.; Van Veldhoven, P.P.; Spengler, B.; Schmitz, G.; et al. Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry. PloS ONE 2018, 13, e0203464. [Google Scholar] [CrossRef] [PubMed]
  16. Nagai, M.; Dote, K.; Kato, M.; Sasaki, S.; Oda, N.; Kagawa, E.; et al. The Insular Cortex and Takotsubo Cardiomyopathy. Curr. Pharm. Des. 2017, 23, 879–888. [Google Scholar] [CrossRef] [PubMed]
  17. Templin, C.; Hanggi, J.; Klein, C.; Topka, M.S.; Hiestand, T.; Levinson, R.A.; et al. Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. Eur. Heart J. 2019, 40, 1183–1187. [Google Scholar] [CrossRef]
  18. Nagai, M.; Kishi, K.; Kato, S. Insular cortex and neuropsychiatric disorders: a review of recent literature. Eur. Psychiatry 2007, 22, 387–394. [Google Scholar] [CrossRef]
  19. George, M.S.; Ketter, T.A.; Parekh, P.I.; Horwitz, B.; Herscovitch, P.; Post, R.M. Brain activity during transient sadness and happiness in healthy women. Am. J. Psychiatry 1995, 152, 341–351. [Google Scholar]
  20. Reiman, E.M.; Lane, R.D.; Ahern, G.L.; Schwartz, G.E.; Davidson, R.J.; Friston, K.J.; et al. Neuroanatomical correlates of externally and internally generated human emotion. Am. J. Psychiatry 1997, 154, 918–925. [Google Scholar]
  21. Damasio, A.R.; Grabowski, T.J.; Bechara, A.; Damasio, H.; Ponto, L.L.; Parvizi, J.; et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat. Neurosci. 2000, 3, 1049–1056. [Google Scholar] [CrossRef]
  22. Gu, X.; Hof, P.R.; Friston, K.J.; Fan, J. Anterior insular cortex and emotional awareness. J. Comp. Neurol. 2013, 521, 3371–3388. [Google Scholar] [CrossRef]
  23. Ulrich-Lai, Y.M.; Herman, J.P. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 2009, 10, 397–409. [Google Scholar] [CrossRef]
  24. Béjean, S.; Sultan-Taïeb, H. Modeling the economic burden of diseases imputable to stress at work. Eur. J. Health Econ. 2005, 6, 16–23. [Google Scholar] [CrossRef]
  25. de Kloet, E.R.; Joëls, M.; Holsboer, F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6, 463–475. [Google Scholar] [CrossRef]
  26. Romier, C.; Bernassau, J.M.; Cambillau, C.; Darbon, H. Solution structure of human corticotropin releasing factor by 1H NMR and distance geometry with restrained molecular dynamics. Protein Eng. 1993, 6, 149–156. [Google Scholar] [CrossRef]
  27. Trainer, P.J.; Faria, M.; Newell-Price, J.; Browne, P.; Kopelman, P.; Coy, D.H.; et al. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J. Clin. Endocrinol. Metab. 1995, 80, 412–417. [Google Scholar]
  28. Hillhouse, E.W.; Grammatopoulos, D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev. 2006, 27, 260–286. [Google Scholar] [CrossRef]
  29. Henckens, M.J.; Deussing, J.M.; Chen, A. Region-specific roles of the corticotropin-releasing factor-urocortin system in stress. Nat. Rev. Neurosci. 2016, 17, 636–651. [Google Scholar] [CrossRef]
  30. Carrasco, G.A.; Van de Kar, L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 2003, 463, 235–272. [Google Scholar] [CrossRef]
  31. McEwen, B.S.; Sapolsky, R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 1995, 5, 205–216. [Google Scholar] [CrossRef]
  32. McEwen, B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998, 338, 171–179. [Google Scholar] [CrossRef]
  33. De Kloet, E.R.; Derijk, R. Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance. Ann. N. Y. Acad. Sci. 2004, 1032, 14–34. [Google Scholar] [CrossRef]
  34. Joëls, M.; Karst, H.; Alfarez, D.; Heine, V.M.; Qin, Y.; van Riel, E.; et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004, 7, 221–231. [Google Scholar] [CrossRef]
  35. Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52, 90–110. [Google Scholar] [CrossRef]
  36. Malta, M.B.; Martins, J.; Novaes, L.S.; Dos Santos, N.B.; Sita, L.; Camarini, R.; et al. Norepinephrine and Glucocorticoids Modulate Chronic Unpredictable Stress-Induced Increase in the Type 2 CRF and Glucocorticoid Receptors in Brain Structures Related to the HPA Axis Activation. Mol. Neurobiol. 2021, 58, 4871–4885. [Google Scholar] [CrossRef]
  37. Allen, A.P.; Kennedy, P.J.; Cryan, J.F.; Dinan, T.G.; Clarke, G. Biological and psychological markers of stress in humans: focus on the Trier Social Stress Test. Neurosci. Biobehav. Rev. 2014, 38, 94–124. [Google Scholar] [CrossRef]
  38. Wallstrom, S.; Ulin, K.; Maatta, S.; Omerovic, E.; Ekman, I. Impact of long-term stress in Takotsubo syndrome: Experience of patients. Eur. J. Cardiovasc. Nurs. 2016, 15, 522–528. [Google Scholar] [CrossRef]
  39. Chan, C.; Elliott, J.; Troughton, R.; Frampton, C.; Smyth, D.; Crozier, I.; et al. Acute myocardial infarction and stress cardiomyopathy following the Christchurch earthquakes. PLoS ONE 2013, 8, e68504. [Google Scholar] [CrossRef]
  40. Sharkey, S.W.; Windenburg, D.C.; Lesser, J.R.; Maron, M.S.; Hauser, R.G.; Lesser, J.N.; et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J. Am. Coll. Cardiol. 2010, 55, 333–341. [Google Scholar] [CrossRef]
  41. Tagawa, M.; Nakamura, Y.; Ishiguro, M.; Satoh, K.; Chinushi, M.; Kodama, M.; et al. Transient left ventricular apical ballooning developing after the Central Niigata Prefecture Earthquake: two case reports. J. Cardiol. 2006, 48, 153–158. [Google Scholar]
  42. Ghadri, J.R.; Sarcon, A.; Diekmann, J.; Bataiosu, D.R.; Cammann, V.L.; Jurisic, S.; et al. Happy heart syndrome: role of positive emotional stress in takotsubo syndrome. Eur. Heart J. 2016, 37, 2823–2829. [Google Scholar] [CrossRef]
  43. Scheitz, J.F.; Mochmann, H.C.; Witzenbichler, B.; Fiebach, J.B.; Audebert, H.J.; Nolte, C.H. Takotsubo cardiomyopathy following ischemic stroke: a cause of troponin elevation. J. Neurol. 2012, 259, 188–190. [Google Scholar] [CrossRef]
  44. Modi, S.; Baig, W. Radiotherapy-induced Tako-tsubo cardiomyopathy. Clin. Oncol. 2009, 21, 361–362. [Google Scholar] [CrossRef]
  45. S, Y.H.; Settergren, M.; Henareh, L. Sepsis-induced myocardial depression and takotsubo syndrome. Acute Card Care 2014, 16, 102–109. [Google Scholar]
  46. Brezina, P.; Isler, C.M. Takotsubo cardiomyopathy in pregnancy. Obstet Gynecol. 2008, 112, 450–452. [Google Scholar] [CrossRef]
  47. Riera, M.; Llompart-Pou, J.A.; Carrillo, A.; Blanco, C. Head injury and inverted Takotsubo cardiomyopathy. J. Trauma. 2010, 68, E13–E15. [Google Scholar] [CrossRef]
  48. Stöllberger, C.; Wegner, C.; Finsterer, J. Seizure-associated Takotsubo cardiomyopathy. Epilepsia 2011, 52, e160–e167. [Google Scholar] [CrossRef]
  49. Hjalmarsson, C.; Oras, J.; Redfors, B. A case of intracerebral hemorrhage and apical ballooning: An important differential diagnosis in ST-segment elevation. Int. J. Cardiol. 2015, 186, 90–92. [Google Scholar] [CrossRef]
  50. Murakami, T.; Yoshikawa, T.; Maekawa, Y.; Ueda, T.; Isogai, T.; Sakata, K.; et al. Gender Differences in Patients with Takotsubo Cardiomyopathy: Multi-Center Registry from Tokyo CCU Network. PLoS ONE 2015, 10, e0136655. [Google Scholar] [CrossRef]
  51. Krishnamoorthy, P.; Garg, J.; Sharma, A.; Palaniswamy, C.; Shah, N.; Lanier, G.; et al. Gender Differences and Predictors of Mortality in Takotsubo Cardiomyopathy: Analysis from the National Inpatient Sample 2009-2010 Database. Cardiology 2015, 132, 131–136. [Google Scholar] [CrossRef]
  52. Yoshizawa, M.; Itoh, T.; Morino, Y.; Taniai, S.; Ishibashi, Y.; Komatsu, T.; et al. Gender Differences in the Circadian and Seasonal Variations in Patients with Takotsubo Syndrome: A Multicenter Registry at Eight University Hospitals in East Japan. Intern. Med. 2021, 60, 2749–2755. [Google Scholar] [CrossRef]
  53. Angelini, P.; Tobis, J.M. Is high-dose catecholamine administration in small animals an appropriate model for takotsubo syndrome? Circ. J. 2015, 79, 897. [Google Scholar] [CrossRef]
  54. Duma, D.; Collins, J.B.; Chou, J.W.; Cidlowski, J.A. Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci. Signal. 2010, 3, ra74. [Google Scholar] [CrossRef]
  55. Lindheim, S.R.; Legro, R.S.; Bernstein, L.; Stanczyk, F.Z.; Vijod, M.A.; Presser, S.C.; et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am. J. Obstet Gynecol. 1992, 167, 1831–1836. [Google Scholar] [CrossRef]
  56. Kudielka, B.M.; Schmidt-Reinwald, A.K.; Hellhammer, D.H.; Kirschbaum, C. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 1999, 70, 422–430. [Google Scholar] [CrossRef]
  57. Ueyama, T.; Hano, T.; Kasamatsu, K.; Yamamoto, K.; Tsuruo, Y.; Nishio, I. Estrogen attenuates the emotional stress-induced cardiac responses in the animal model of Tako-tsubo (Ampulla) cardiomyopathy. J. Cardiovasc Pharmacol. 2003, 42, S117–S119. [Google Scholar] [CrossRef]
  58. Ueyama, T.; Ishikura, F.; Matsuda, A.; Asanuma, T.; Ueda, K.; Ichinose, M.; et al. Chronic estrogen supplementation following ovariectomy improves the emotional stress-induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart. Circ. J. 2007, 71, 565–573. [Google Scholar] [CrossRef]
  59. Rivera, C.M.; Grossardt, B.R.; Rhodes, D.J.; Brown, R.D.; Jr Roger, V.L.; Melton, L.J., 3rd; et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009, 16, 15–23. [Google Scholar] [CrossRef]
  60. Brenner, R.; Weilenmann, D.; Maeder, M.T.; Jörg, L.; Bluzaite, I.; Rickli, H.; et al. Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy. Clin. Cardiol. 2012, 35, 340–347. [Google Scholar] [CrossRef]
  61. Zhao, D.; Guallar, E.; Ouyang, P.; Subramanya, V.; Vaidya, D.; Ndumele, C.E.; et al. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women. J. Am. Coll. Cardiol. 2018, 71, 2555–2566. [Google Scholar] [CrossRef]
  62. Barros, R.P.; Machado, U.F.; Gustafsson, J.A. Estrogen receptors: new players in diabetes mellitus. Trends. Mol. Med. 2006, 12, 425–431. [Google Scholar] [CrossRef]
  63. Zhu, Y.; Bian, Z.; Lu, P.; Karas, R.H.; Bao, L.; Cox, D.; et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002, 295, 505–508. [Google Scholar] [CrossRef]
  64. Komesaroff, P.A.; Esler, M.D.; Sudhir, K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J. Clin. Endocrinol. Metab. 1999, 84, 606–610. [Google Scholar] [CrossRef]
  65. Sung, B.H.; Ching, M.; Izzo, J.L.; Jr Dandona, P.; Wilson, M.F. Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women. J. Hypertens. 1999, 17, 523–528. [Google Scholar] [CrossRef]
  66. Sader, M.A.; Celermajer, D.S. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc. Res. 2002, 53, 597–604. [Google Scholar] [CrossRef]
  67. Forster, C.; Kietz, S.; Hultenby, K.; Warner, M.; Gustafsson, J.A. Characterization of the ERbeta-/-mouse heart. Proc. Natl. Acad. Sci. USA 2004, 101, 14234–14239. [Google Scholar] [CrossRef]
  68. Dimberg, U.; Petterson, M. Facial reactions to happy and angry facial expressions: evidence for right hemisphere dominance. Psychophysiology 2000, 37, 693–696. [Google Scholar] [CrossRef]
  69. Drača, S. A possible relationship between Takotsubo cardiomyopathy and female sex steroid-related modulation of functional cerebral asymmetry. Med. Hypotheses 2015, 84, 238–240. [Google Scholar] [CrossRef]
  70. Singh, K.; Carson, K.; Shah, R.; Sawhney, G.; Singh, B.; Parsaik, A.; et al. Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy. Am. J. Cardiol. 2014, 113, 1420–1428. [Google Scholar] [CrossRef]
  71. Pelliccia, F.; Parodi, G.; Greco, C.; Antoniucci, D.; Brenner, R.; Bossone, E.; et al. Comorbidities frequency in Takotsubo syndrome: an international collaborative systematic review including 1109 patients. Am. J. Med. 2015, 128, e11–e19. [Google Scholar] [CrossRef]
  72. Pelliccia, F.; Sinagra, G.; Elliott, P.; Parodi, G.; Basso, C.; Camici, P.G. Takotsubo: One, no one and one hundred thousand diseases. Int. J. Cardiol. 2018, 261, 35. [Google Scholar] [CrossRef]
  73. Jänig, W. The Integrative Action of the Autonomic Nervous System: Neurobiology of Homeostasis; Cambridge University Press: Cambridge, UK, 2006. [Google Scholar]
  74. Li, Y.; Jiang, W.; Li, Z.Z.; Zhang, C.; Huang, C.; Yang, J.; et al. Repetitive restraint stress changes spleen immune cell subsets through glucocorticoid receptor or β-adrenergic receptor in a stage dependent manner. Biochem. Biophys. Res. Commun. 2018, 495, 1108–1114. [Google Scholar] [CrossRef]
  75. Duma, D.; Jewell, C.M.; Cidlowski, J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid. Biochem. Mol. Biol. 2006, 102, 11–21. [Google Scholar] [CrossRef]
  76. Rhen, T.; Cidlowski, J.A. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N. Engl. J. Med. 2005, 353, 1711–1723. [Google Scholar] [CrossRef]
  77. Nagai, M.; Forster, C.Y.; Dote, K. Sex Hormone-Specific Neuroanatomy of Takotsubo Syndrome: Is the Insular Cortex a Moderator? Biomolecules 2022, 12. [Google Scholar] [CrossRef]
  78. Walsh, C.P.; Bovbjerg, D.H.; Marsland, A.L. Glucocorticoid resistance and β2-adrenergic receptor signaling pathways promote peripheral pro-inflammatory conditions associated with chronic psychological stress: A systematic review across species. Neurosci. Biobehav. Rev. 2021, 128, 117–135. [Google Scholar] [CrossRef]
  79. Walsh, C.P.; Ewing, L.J.; Cleary, J.L.; Vaisleib, A.D.; Farrell, C.H.; Wright, A.G.C.; et al. Development of glucocorticoid resistance over one year among mothers of children newly diagnosed with cancer. Brain Behav. Immun. 2018, 69, 364–373. [Google Scholar] [CrossRef]
  80. Capitanio, J.P.; Mendoza, S.P.; Lerche, N.W.; Mason, W.A. Social stress results in altered glucocorticoid regulation and shorter survival in simian acquired immune deficiency syndrome. Proc. Natl. Acad. Sci. USA 1998, 95, 4714–4719. [Google Scholar] [CrossRef]
  81. Cole, S.W.; Mendoza, S.P.; Capitanio, J.P. Social stress desensitizes lymphocytes to regulation by endogenous glucocorticoids: insights from in vivo cell trafficking dynamics in rhesus macaques. Psychosom. Med. 2009, 71, 591–597. [Google Scholar] [CrossRef]
  82. Cole, S.W.; Capitanio, J.P.; Chun, K.; Arevalo, J.M.; Ma, J.; Cacioppo, J.T. Myeloid differentiation architecture of leukocyte transcriptome dynamics in perceived social isolation. Proc. Natl. Acad. Sci. USA 2015, 112, 15142–15147. [Google Scholar] [CrossRef]
  83. Oakley, R.H.; Cidlowski, J.A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 2013, 132, 1033–1044. [Google Scholar] [CrossRef]
  84. Gonzalez Ramirez, C.; Villavicencio Queijeiro, A.; Jimenez Morales, S.; Barcenas Lopez, D.; Hidalgo Miranda, A.; Ruiz Chow, A.; et al. The NR3C1 gene expression is a potential surrogate biomarker for risk and diagnosis of posttraumatic stress disorder. Psychiatry Res. 2020, 284, 112797. [Google Scholar] [CrossRef]
  85. Ueyama, T.; Kasamatsu, K.; Hano, T.; Yamamoto, K.; Tsuruo, Y.; Nishio, I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: a possible animal model of ‘tako-tsubo’ cardiomyopathy. Circ. J. 2002, 66, 712–713. [Google Scholar] [CrossRef]
  86. Kume, T.; Kawamoto, T.; Okura, H.; Toyota, E.; Neishi, Y.; Watanabe, N.; et al. Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ. J. 2008, 72, 106–108. [Google Scholar] [CrossRef]
  87. Ortak, J.; Khattab, K.; Barantke, M.; Wiegand, U.K.; Bänsch, D.; Ince, H.; et al. Evolution of cardiac autonomic nervous activity indices in patients presenting with transient left ventricular apical ballooning. Pacing Clin. Electrophysiol. 2009, 32, S21–S25. [Google Scholar] [CrossRef]
  88. Vaccaro, A.; Despas, F.; Delmas, C.; Lairez, O.; Lambert, E.; Lambert, G.; et al. Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. PLoS ONE 2014, 9, e93278. [Google Scholar] [CrossRef]
  89. Pelliccia, F.; Kaski, J.C.; Crea, F.; Camici, P.G. Pathophysiology of Takotsubo Syndrome. Circulation 2017, 135, 2426–2441. [Google Scholar] [CrossRef]
  90. Ferrucci, L.; Semba, R.D.; Guralnik, J.M.; Ershler, W.B.; Bandinelli, S.; Patel, K.V.; et al. Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010, 115, 3810–3816. [Google Scholar] [CrossRef]
  91. Cohen, H.J.; Pieper, C.F.; Harris, T.; Rao, K.M.; Currie, M.S. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. A Biol. Sci. Med. Sci. 1997, 52, M201–M208. [Google Scholar] [CrossRef]
  92. Newman, A.B.; Sanders, J.L.; Kizer, J.R.; Boudreau, R.M.; Odden, M.C.; Zeki Al Hazzouri, A.; et al. Trajectories of function and biomarkers with age: the CHS All Stars Study. Int. J. Epidemiol. 2016, 45, 1135–1145. [Google Scholar] [CrossRef]
  93. Gerli, R.; Monti, D.; Bistoni, O.; Mazzone, A.M.; Peri, G.; Cossarizza, A.; et al. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech. Ageing Dev. 2000, 121, 37–46. [Google Scholar] [CrossRef]
  94. Pallauf, K.; Rimbach, G. Autophagy, polyphenols and healthy ageing. Ageing Res. Rev. 2013, 12, 237–252. [Google Scholar] [CrossRef]
  95. Salminen, A.; Kaarniranta, K.; Kauppinen, A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging 2012, 4, 166–175. [Google Scholar] [CrossRef]
  96. O’Donovan, A.; Pantell, M.S.; Puterman, E.; Dhabhar, F.S.; Blackburn, E.H.; Yaffe, K.; et al. Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS ONE 2011, 6, e19687. [Google Scholar] [CrossRef] [PubMed]
  97. Shiels, P.G.; McGlynn, L.M.; MacIntyre, A.; Johnson, P.C.; Batty, G.D.; Burns, H.; et al. Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS One 2011, 6, e22521. [Google Scholar] [CrossRef] [PubMed]
  98. Aviv, A.; Valdes, A.; Gardner, J.P.; Swaminathan, R.; Kimura, M.; Spector, T.D. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J. Clin. Endocrinol. Metab. 2006, 91, 635–640. [Google Scholar] [CrossRef] [PubMed]
  99. Houben, J.M.; Moonen, H.J.; van Schooten, F.J.; Hageman, G.J. Telomere length assessment: biomarker of chronic oxidative stress? Free Radic. Biol. Med. 2008, 44, 235–246. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated